VERTEX-DENTAL ASIA PTE. LTD. - Результаты поиска

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

regaine for women once a day 5% scalp foam

mcneil products ltd - minoxidil - cutaneous foam - 50mg/1gram

Австралия - английский - Department of Health (Therapeutic Goods Administration)

orkambi 100/125 lumacaftor/ivacaftor 100 mg/125 mg film-coated tablet blister pack

vertex pharmaceuticals australia pty ltd - ivacaftor, quantity: 125 mg; lumacaftor, quantity: 100 mg - tablet, film coated - excipient ingredients: hypromellose acetate succinate; sodium lauryl sulfate; microcrystalline cellulose; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified water; purified talc; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350; cochineal; indigo carmine aluminium lake; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

orkambi 150/188 lumacaftor/ivacaftor 150mg/188mg granules sachet

vertex pharmaceuticals australia pty ltd - lumacaftor, quantity: 150 mg; ivacaftor, quantity: 188 mg - granules - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; povidone; sodium lauryl sulfate; hypromellose acetate succinate - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

orkambi 100/125 lumacaftor/ivacaftor 100mg/125mg granules sachet

vertex pharmaceuticals australia pty ltd - lumacaftor, quantity: 100 mg; ivacaftor, quantity: 125 mg - granules - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; povidone; sodium lauryl sulfate; hypromellose acetate succinate - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

finasteride mylan 1 finasteride 1 mg film-coated tablet blister pack

accord healthcare pty ltd - finasteride, quantity: 1 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate type a; magnesium stearate; lauroyl macrogolglycerides; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red - finasteride mylan is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. efficacy has not been demonstrated in men over the age of 41 years. finasteride mylan is not indicated for use in women (see use in pregnancy and clinical studies) or children.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

finasta finasteride1 mg film-coated tablet blister pack

sandoz pty ltd - finasteride, quantity: 1 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate type a; magnesium stearate; lauroyl macrogolglycerides; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red - finasta is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. efficacy has not been demonstrated in men over the age of 41 years. finasta is not indicated for use in women (see use in pregnancy and clinical studies) or children.